Company intelligence / Profile preview

Promomed

Moscow, Central Federal District, Russiapromomed.ru ↗

Ownership: Private
Employees: ~2000
Development stage: Commercial

Overview

Promomed is one of Russia’s leading innovative biopharmaceutical companies with over 250 registered drugs—80% on the national list of vital medicines. It has launched several COVID‑19 treatments such as Esperavir and Skyvira. The company is #1 in clinical trials in Russia for 2022–2023 and leads the market in obesity treatment. Its pipeline includes branded blockbusters and innovative small molecules across multiple therapeutic areas including oncology and metabolic health. Clinical results include successful launches of COVID‑19 antivirals granted marketing authorization by Russian regulators.

Therapeutic areas: Metabolic DisordersRheumatologyEndocrinologyOncologyNeurologyInfectious Diseases
Modalities: Small moleculesBiotech products (including biosimilars)
Industry: Biotech

Drug pipeline

8 assets

Reduxin Forte

7 more assets in the full pipeline.

Request access →

Partnerships

Government partnerships include agreements with the Government of Moscow to establish new research centers/manufacturing facilities within Technopolis Moscow SEZFederal project “Professionality” partnership via Biokhimik manufacturing facility

Beyond the preview

Go deeper on Promomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Promomed.

Explore the full profile